The earlier microalbuminuria is detected, the better the chance of targeting CKD and CVD while their progression can be stopped. Yet because microalbuminuria is not accompanied by noticeable symptoms, its detection among those at risk depends on you who work in primary care.¹ Fortunately, screening for microalbuminuria in primary care is natural and convenient, thanks to the availability of accurate point-ofcare tests. But most importantly, it has the potential to reach those groups that the ISN has in focus. People with type 2 diabetes or hypertension are most often treated in primary care. And those in the risk zone for either condition, especially if they are older than 50, are likely to undergo annual check-ups. At the very least, people in all of these groups seek out primary care for medical advice or the examination of general symptoms.²